<?xml version="1.0" encoding="UTF-8"?>
<p id="Par39">The changes of ACFs number in each group, the primary endpoint, will be compared between the aspirin plus placebo group and the aspirin plus metformin group by the Student 
 <italic>t</italic> test. The safety, one of the secondary endpoints, will be compared by the chi-square test. The remaining results in the two groups will be compared by the Mann-Whitney 
 <italic>U</italic> test or the 
 <italic>t</italic>-test. A 
 <italic>P</italic> values of &lt;â€‰0.05 will be regarded as indicative of statistical significance. The analysis will be performed using SPSS statistics, version 26 (SPSS, Chicago, IL, USA).
</p>
